IL7 and acute lymphoblastic leukemia: Overall, our studies and those of Durum and collaborators, demonstrate the feasibility, and the underlying promise for further developments, of antibody-based strategies targeting IL-7R for the treatment of T-ALL and other pathological conditions in which IL-7 and IL-7R have a role.